Effects of Mental Disorders on Fibromyalgia Mediated by Insomnia: A Mendelian Randomization Study

Le Chang1, Zhen Sun1, Shiyong Zeng2

  • 1Department of Clinical Medicine, Quanzhou Medical College, Quanzhou, Fujian, People's Republic of China.

Journal of Pain Research
|December 20, 2024
PubMed
Abstract

Insights

Mental health conditions like depression and irritability, along with insomnia, are causally linked to fibromyalgia. Insomnia partially mediates these effects, offering insights for fibromyalgia prevention and treatment strategies.

Area of Science:

  • Genetics and Epidemiology
  • Psychiatry
  • Pain Medicine

Background:

  • Fibromyalgia is a complex chronic pain condition with poorly understood etiology.
  • The potential causal links between mental health disorders and fibromyalgia require robust investigation.

Purpose of the Study:

  • To investigate the causal relationship between specific mental disorders (depression, irritability) and insomnia with fibromyalgia.
  • To examine the mediating role of insomnia in the association between mental disorders and fibromyalgia.

Main Methods:

  • Mendelian randomization (MR) analysis utilizing summary data from large-scale genome-wide association studies (GWAS).
  • Selection of single-nucleotide polymorphisms (SNPs) based on stringent statistical criteria (p < 5×10-8, r2 < 0.001, kb = 10,000).
  • Application of inverse variance weighted (IVW) and other MR methods, with sensitivity analyses for result validation.

Main Results:

  • Confirmed positive causal associations between depression, irritability, and insomnia with fibromyalgia.
  • Identified positive causal relationships between depression and irritability with insomnia.
  • Multivariate MR revealed that insomnia mediates 25.2%–26% of the effect of depression and irritability on fibromyalgia.

Conclusions:

  • Depression, irritability, and insomnia are causally associated with an increased risk of fibromyalgia.
  • Insomnia plays a significant mediating role in the pathway from depression and irritability to fibromyalgia.
  • Findings support the development of targeted interventions for fibromyalgia by addressing mental health and sleep disturbances.

Related Concept Videos

Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
79
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
230
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
73
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
56
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
45